Du, Jianhua
Jiang, Yinan
Lloyd, Cathy
Sartorius, Norman
Ren, Jie
Zhao, Weigang
Wei, Jing
Hong, Xia
Funding for this research was provided by:
Capital Funds for Health Improvement and Research (CFH2022-2-4012, CFH2022-2-4012, CFH2022-2-4012, CFH2022-2-4012, CFH2022-2-4012, CFH2022-2-4012)
International Prevalence and Treatment of Diabetes and Depression ‐-InterPreTDD
Article History
Received: 22 June 2023
Accepted: 15 November 2023
First Online: 29 November 2023
Declarations
:
: As part of the International Diabetes and Depression Comorbidity and Treatment research, the researchers obtained ethical approval from the institutional review board of Peking Union Medical College Hospital (registered under number S-713). All methods were carried out with accordance with the Declaration of Helsinki. In addition, written informed consent was obtained from all participants. For illiterate participants, written informed consents were obtained from their legal guardians.
: Not applicable since the study did not contain any identifiable information or images of participants.
: The authors declare no competing interests.